Finally, through experimental verification, it was found that LJF can significantly downregulate the expression of CASP3 and TNF-α in the NAFLD cell model, and finally play a therapeutic role in NAFLD. This evidence concerns the gene CASP3 and metabolic dysfunction-associated steatotic liver disease.